Overview

A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)

Status:
Withdrawn

Trial end date:
2021-09-01

Target enrollment:

Participant gender:

Summary

A comparison of Malaria events (symptoms and signs of malaria) experienced by subjects infected with PfSPZ Challenge (NF54) vs. PfSPZ Challenge (7G8).

Phase:

N/A

Details

Lead Sponsor:

U.S. Army Medical Research and Development Command

Collaborator:

Naval Medical Research Center

Treatments:

Artemether
Artemether, Lumefantrine Drug Combination
Atovaquone
Atovaquone, proguanil drug combination
Lumefantrine
Proguanil
Vaccines